Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.

BACKGROUND: Recognizing resistance or susceptibility to the current standard cisplatin and paclitaxel treatment could improve therapeutic outcomes of metastatic or recurrent cervical cancer. METHODS: Forty-five tissue samples from patients participating in a phase II trial of cisplatin and ifosfamid...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMC Cancer
Prif Awduron: Karageorgopoulou, Sofia, Kostakis, Ioannis D., Gazouli, Maria, Markaki, Sonia, Papadimitriou, Marios, Bournakis, Evangelos, Dimopoulos, Meletios-Athanassios, Papadimitriou, Christos A
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2017
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5490227/
https://ncbi.nlm.nih.gov/pubmed/28659181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3435-x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg